Evaluation of the effects of a supplementary diet containing chicken comb extract on symptoms and cartilage metabolism in patients with knee osteoarthritis

Experimental and Therapeutic Medicine

Volumn 1, Issue 5, 2010, Pages 817-827

  Nagaoka, Isao ^a   Nabeshima, Kunihiro ^c   Murakami, Saya ^c   Yamamoto, Tetsuro ^b   Watanabe, Keita ^d   Tomonaga, Akihito ^e   Yamaguchi, Hideyo ^b  

^a JUNTENDO UNIVERSITY   (Japan)

^b TOTAL   (France)

^c Everlife Co Ltd   (Japan)

^d Kitashinyokohama Orthopedic Surgery   (Japan)

^e TANA Orthopedic Surgery   (Japan)

Author keywords

Biomarker; Hyaluronic acid; Osteoarthritis; Supplementary diet; Type II collagen

Indexed keywords

C TERMINAL CROSS LINKED TELOPEPTIDE OF COLLAGEN TYPE II; C TERMINAL PROPEPTIDE OF TYPE II COLLAGEN PROCOLLAGEN; CARBOXY TERMINAL TELOPEPTIDE; CHICKEN COMB EXTRACT; COLLAGEN TYPE 2; COLLAGEN TYPE II C2C NEOPEPTIDE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HYALURONIC ACID; PLACEBO; UNCLASSIFIED DRUG;

ABDOMINAL CRAMP; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARTILAGE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COLLAGEN METABOLISM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG EFFICACY; FEMALE; FUNCTIONAL STATUS; HUMAN; KINESIOTHERAPY; KNEE OSTEOARTHRITIS; MALE; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; STOMACH DISCOMFORT; TREATMENT OUTCOME; TREATMENT RESPONSE; URINALYSIS; VISUAL ANALOG SCALE; WALKING;

EID: 77955225110     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2010.114     Document Type: Article

References (30)

1. Gupta S, Hawker GA, Laporte A, Croxford R and Coyte PC: The economic burden of disabling hip and knee osteoarthritis (OA) from the perspective of individuals living with this condition. Rheumatology 44: 1531-1537, 2005.
2. Yoshimura N, Oka H, Muraki S, et al: Epidemiology of osteoarthritis in Japan. J Jpn Orthop Assoc (In Japanese) 81: 17-21, 2007.
3. Budewalter JA, Stanish WD, Rosier RN, Schenck RCJr, DennisDAand Coutts RD: The increasing need for nonoperative treatment of patients with osteoarthritis. Clin Orthop 385: 36-45, 2001.
4. Rashad S, Revell P, Hemmingway A, Low F, Rainsford K and Walker F: Effect of non-steroidal anti-inflammatory drugs on the course of osteoarthritis. Lancet 2: 519-522, 1989
5. Clayton JJ: Nutraceuticals in the management of osteoarthritis. Orthopedics 30: 624-629, 2007.
6. Verbruggen G: Chondroprotective drugs in degenerative joint diseases. Rheumatology 45: 129-138, 2005.
7. Goldberg VM and Buckwalter JA: Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity. Osteoarthritis Cartilage 13: 216-224, 2005.
8. Petrella RT: Hyaluronic acid for the treatment of knee osteoarthritis: long-term outcomes from a naturalistic primary care experience. Am J Phys Med Rehabil 84: 278-283, 2005.
9. Sun SF, Hsu CW, Hwang CW, Hsu PT, Wang JL, Tsai SL, ChouYJ, Hsu YW, Huang CM and Wang YL: Hyaluronate improves pain, physical function and balance in the geriatric, osteoarthritic knee: a 6-month follow-up study using clinical tests. Osteoarthritis Cartilage 14: 696-701, 2006.
10. Hunter DJ and Hellio Le Graver and Gastineau M-P: How close are we to having structure-modifying drugs available Rheum Dis Clin NAm 34: 789-802, 2008.
11. Gossec L and Dougados M: Intra-articular treatments in osteoarthritis: from the symptomatic to the structure modifying. Ann Rheum Dis 63: 478-482, 2004.
12. Patti AM, Gabriele A, Vulcano A, Ramieri MT and DellaRoccaC: Effect of hyaluronic acid on human chondrocytes cell lines from articular cartilage. Tissue Cell 33: 294-300, 2001.
13. Akmal M, Siingh A, Anand A, Kesani A, Aslam N, GoodshipA and Bentley G: The effects of hyaluronic acid on articular chondrocytes. J Bone Joint Surg Br 87: 1143-1149, 2005.
14. Adams ME, Lussier AJ and Peyron JG: A risk-benefit assessment of injections of hyaluronan and its derivatives in the treatment of knee osteoarthritis. Drug Saf 23: 115-130, 2000.
15. Huang SL, Ling PX and Zhang TM: Oral absorption of hyaluronic acid and phospholipids complexes in rats. World J Gastroenterol 13: 945-949, 2007.
16. Hatayama T, Nagano M and Yamaguchi N, Kumagai S and OhnukiK: The effect of a supplement on knee pain and discomfort evaluated by visual analog scale (VAS): a randomized, double-blind, placebo-controlled study (in Japanese). Kenko-shien 10: 13-17, 2008.
17. Ravaud P, Giraudean B, Auleley GR, Drape JL, Rousselin B, Paolozzi L, Chastang C and Dougados M: Variability in knee radiographing: implication for definition of radiological progression in medical knee osteoarthritis. Ann Rheum Dis 57: 624-629, 1998.
18. Vignon E, Garnero P, Delmas P, Avouac B, Bettica P, BoersM, Ehrich E, MacKillop N, Rovati L, Serni U, Spector T and Reginster JY: Recommendations for the registiation of drugs used in the treatment of osteoarthritis: an update on biochemical markers. Osteoarthritis Cartilage 9: 289-293, 2001.
19. Garnero P and Delmas PD: Biomarkers in osteoarthritis. Nature Clin Pract Rheumatol 3: 346-356, 2007.
20. Poole AR, Ionescu M, Fitzcharles MA and Billinghurst RC: The assessment of cartilage degradation in vivo: development of an immunoassay for the measurement of in body fluids of type II collagen cleared by collagenases. J Immunol Methods 294: 145-153, 2004.
21. Garnero P, Ayral X, Rousseau JC, Christgau S, Sandell LJ, Dougados M and Delmas P: Uncoupling of type IIcollagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Arthritis Rheum 46: 2613-2624, 2002.
22. Cahue S, Sharma L, Dunlop D, Ionescu M, Song J, Lobanok T, King L and Poole AR: The ratio of type IIcollagen breakdown to synthesis and its relationship with the progression of knee osteoarthritis. Osteoarthritis Cartilage 15: 819-823, 2007.
23. Sato T and Iwaso H: An effectiveness study of hyaluronic acid [Hyabest® (J)] in the treatment of osteoarthritis of the knee on patients in the United States. J New Rem Clin 58: 249-256, 2009.
24. Kalman DS, Heimer M, Valdeon A, Schwartz H and Sheldon E: Effect of a natural extract of chicken combs with a high content of hyaluronic acid (Hyal-Joint®) on pain relief and quality of life in subjects with knee osteoarthritis: a pilot randomized double-blind placebo-controlled trial. Nutrition J 7: 3, 2008.
25. Fransen M, McConnell S and Bell M: Exercise for osteoarthritis of the hip or knee. Cochrane Database Syst Rev (CD004286), 2003.
26. Roos EM and Dahlberg L: Positive effects of moderate exercise on glycosaminoglycan content in knee cartilage: a four-month, randomized, controlled trial in patients at risk of osteoarthritis. Arthritis Rheum 52: 3507-3514, 2005.
27. Christgau S, Henrotin Y, Tankó LB, Rovati LC, Collette J, Bruyere O.Deroisy R and Reginster JY: Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulfate. Clin Exp Rheumatol 22: 36-42, 2004.
28. Cibere J, Thorne A, Kopec JA, Singer J, Canvin J, Robinson DB, Pope J, Hong P, Grant E, Lobanok T, Ionescu M, Poole AR and Esdaile JM: Glucosamine sulfate and cartilage type IIcollagen degradation in patients with knee osteoarthritis. J Rheumatol 32: 896-902, 2005.
29. Mazières B, Hucher M, Zaïm M and Garnero P: Effect of chondroitin sulfate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study. Ann Rheum Dis 66: 639-645, 2007.
30. Bay-Jensen AC, Andersen TL, Charni-Ben Tabassi N, KristensenPW, Kjaersgaard-Andersen P, Sandell L, GarneroP and Delaissé JM: Biochemical markers of type IIcollagen breakdown and synthesis are positioned at specific sites in human osteoarthritic knee cartilage. Osteoarthritis Cartilage 16: 615-623, 2008